| Date | Title | Description | Source |
| 31.10.2023 | Abingworth: Transatlantic Life Sciences Investment Firm Clos... | Abingworth – a leading international life sciences investment group, part of global investment firm ... | pulse2.com... |
| 30.10.2023 | Abingworth closes $356M fund for late-stage biopharma progra... | Investor Abingworth has closed a new $356 million fund specifically designed to co-develop late-stag... | fiercebiot... |
| 30.10.2023 | Abingworth Closes Clinical Co-Development Co-Investment Fund... | Abingworth, a global life sciences investment firm, closed its new Clinical Co-Development Co-Invest... | finsmes.co... |
| 30.10.2023 | Carlyle’s life science investor Abingworth scores over $350m... | | altassets.... |
| 30.10.2023 | Abingworth raises $356 million for new Clinical Co-Developme... | - | globenewsw... |
| 23.10.2023 | Which VCs are investing in rare diseases? | Firms include Chiesi Ventures, Frazier Healthcare Partners, OrbiMed, and Atlas Venture
In the United... | vator.tv/n... |
| 12.04.2022 | Carlyle's acquisition of Abingworth brings $2 billion to fue... | Small but mighty transatlantic investment firm Abingworth has caught the attention—and appetite—of t... | fiercebiot... |
| 11.04.2022 | Paradigm, Andreessen Horowitz, and Union Square Ventures sue... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 11.04.2022 | Private equity giant Carlyle to acquire biotech venture capi... | The Carlyle Group will acquire Abingworth, one of biotech’s oldest venture capital groups, it announ... | statnews.c... |
| 16.09.2021 | Anjarium Biosciences Raises CHF 55.5 Million Series A Financ... | | startuptic... |
| 02.08.2021 | CymaBay Therapeutics : Announces $100 Million Non-Dilutive F... | Risk-sharing agreement with Abingworth will fund seladelpar Phase 3 development program for PBC
Cyma... | marketscre... |
| 02.08.2021 | CymaBay Announces $100 Million Non-Dilutive Financing with A... | - | abingworth... |
| 10.05.2021 | Abingworth raises $582 million for new Clinical Co-Developme... | - | abingworth... |
| 08.05.2021 | Abingworth raises $582M clinical co-development fund amid ri... | Abingworth has raised $582 million for its second clinical co-development fund. The fund, ACCD 2, eq... | fiercebiot... |
| 04.02.2021 | Abingworth closes latest life sciences fund on $465M | London-based life sciences investor Abingworth has closed its eighth transatlantic venture fund on $... | pitchbook.... |
| 03.02.2021 | Abingworth raises $465m for new life sciences fund Abingwort... | - | abingworth... |
| 03.02.2021 | Abingworth raises $465m for new life sciences venture fund | - | venturecap... |
| 03.02.2021 | Abingworth raises $465M fund, steps up interest in CNS disea... | Abingworth has raised a $465 million life sciences fund, positioning it to build on earlier investme... | fiercebiot... |
| 09.12.2020 | Reneo Pharmaceuticals Raises $95 Million in Series B Financ... | SAN DIEGO, Dec. 9, 2020 /PRNewswire/ -- Reneo Pharmaceuticals, Inc. today announced it raised $95 mi... | marketscre... |
| 09.12.2020 | Congratulations to the Reneo team on their $95 Million Serie... | - | abingworth... |
| 20.02.2020 | Spruce Biosciences Raises $88 Million in Series B Financing,... | - | abingworth... |
| 19.02.2020 | Spruce Biosciences Raises $88 Million in Series B Financing,... | – Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indica... | aislingcap... |
| 26.03.2019 | Abingworth Appoints Bali Muralidhar as Partner | Abingworth, a London, UK-based international investment group dedicated to life sciences, appointed ... | finsmes.co... |
| 09.07.2018 | Abingworth raises $315M to place transatlantic biotech bets | Abingworth has raised a $315 million (€267 million) life sciences venture fund. The British VC shop ... | fiercebiot... |
| 09.07.2018 | Abingworth Closes Abingworth Bioventures VII, at $315M | Abingworth, an international investment group focused on life sciences, closed its latest fund, Abin... | finsmes.co... |
| 09.07.2018 | Term Sheet — Monday, July 9 | UNDER FIRE
Good morning, Term Sheet readers.
Paid Content How can you protect what you can't see? Fr... | fortune.co... |
| 06.11.2017 | 5AM Ventures Joins 42M Euros Series B for NousCom | NousCom, an oncology company developing neoantigen based cancer vaccines based on its Exovax platfor... | citybizlis... |
| 06.11.2017 | NousCom secures €42 Million in Series B Financing | | startuptic... |
| 06.11.2017 | Versant Ventures Joins 42M Euros Series B for NousCom | NousCom, an oncology company developing neoantigen based cancer vaccines based on its Exovax platfor... | citybizlis... |
| 25.07.2017 | Abingworth Joins $42M Series B for VenatoRx Pharmaceuticals | MALVERN, Pa.--(BUSINESS WIRE)--VenatoRx Pharmaceuticals, Inc., a biopharmaceutical company developin... | citybizlis... |
| 21.01.2016 | Abingworth Closes 11th Life Sciences Fund, at $105M | Abingworth, an international investment group dedicated to life sciences, closed its 11th life scien... | finsmes.co... |
| 30.04.2015 | CRISPR Therapeutics Raises Additional $64 Million | | startuptic... |
| 03.06.2014 | Senseonics raised $20 million to advance continuous glucose ... | Pivotal trials have begun in Amsterdam and are scheduled for this summer in Germany and the UK and t... | medcitynew... |
| 16.05.2014 | Proteon Therapeutics Raises $45M in Series D Equity Financin... | Proteon Therapeutics Inc., a Waltham, Mass.-based biopharmaceutical company developing pharmaceutica... | finsmes.co... |
| 17.04.2014 | Wilson Therapeutics Receives $40M in Series B Funding | Wilson Therapeutics, a Stockholm, Sweden-based biopharmaceutical company, received $40m in Series B ... | finsmes.co... |
| 28.02.2014 | Abingworth Closes £225m Fourth Fund | Abingworth, an international investment group dedicated to life sciences and healthcare, held the fi... | finsmes.co... |
| 20.05.2013 | eFFECTOR Therapeutics Completes $45M Series A Financing | eFFECTOR Therapeutics, a San Diego, CA-based newly formed biopharmaceutical company, completed a $45... | finsmes.co... |
| 20.02.2013 | Gynesonics Raises $21M Series D Funding | Gynesonics Inc., a Redwood City, California-based women’s healthcare company, raised a $21m Series D... | finsmes.co... |
| 28.01.2013 | Avillion Receives Funding from Abingworth and Clarus Venture... | Avillion LLP, a London, UK-based company that focuses on clinical co-development of therapeutics, re... | finsmes.co... |
| 04.06.2012 | Student-Led Wolverine Venture Fund Invests in Sonitus Medica... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The Wolverine Venture Fund, a $5.5 ... | xconomy.co... |
| 29.03.2012 | Sientra Closes $65M Series C Financing | Sientra, a Santa Barbara, CA-based medical device company focused on the aesthetic and plastic surge... | finsmes.co... |
| 28.12.2011 | Minnesota medical device company targeting scoliosis raises ... | KSpine Inc. is led by CEO Fred W. Kornahrens. Longhini,who also is co-founder of Voyageur Medical, a... | medcitynew... |
| 18.05.2011 | MD On-Line Receives Minority Investment from Abingworth | MD On-Line, Inc., a Parsippany, NJ-based provider of electronic data interchange (EDI) solutions tha... | finsmes.co... |
| 05.05.2010 | Secure EDI Receives Significant Investment from Abingworth | Secure EDI, a North Carolina, US-based healthcare transactions integrator, creating electronic inter... | finsmes.co... |
| 05.12.2008 | Broncus inhales $38M to treat lung disease, eyes IPO | Broncus Technologies, developer of devices to treat emphysema and other lung ailments, may make a se... | venturebea... |
| 01.10.2008 | Pathwork Diagnostics raises $20M for cancer diagnostic tests | Pathwork Diagnostics, a Sunnyvale, Calif.-based maker of cancer diagnostic tets, has raised $20 mill... | venturebea... |
| 24.06.2008 | Broncus Technologies lines up venture debt financing for emp... | Broncus Technologies pulled its initial public offering plans last week and now intends to line up v... | venturebea... |
| 08.05.2007 | Cardiovascular biotech Portola Pharmaceuticals raises $70M, ... | Portola Pharmaceuticals, a South San Francisco, Calif., biotech aiming to develop treatments for blo... | venturebea... |
| 29.09.2004 | Amadeus leads $14.4 million Series B financing in Solexa | Amadeus leads $14.4 million Series B financing in Solexa
29-09-2004
Amadeus Capital Partners has led... | cambridgen... |
| 01.04.2004 | Abingworth wins Private Equity Awards | Abingworth wins Private Equity Awards
01-04-2004
Abingworth Management, the life sciences venture ca... | cambridgen... |
| 16.08.2002 | Abingworth appoints in-house legal advisor | Abingworth appoints in-house legal advisor
16-08-2002
Abingworth, the life sciences venture capital ... | cambridgen... |
| - | Spruce Biosciences Raises $88 Million in Series B Financing,... | – Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indica... | healthcap.... |
| - | Minnesota medical device company targeting scoliosis raises ... | A Minnesota medical device company has raised $2.5 million in its second round of financing, accordi... | medcitynew... |
| - | Senseonics raised $20 million to advance continuous glucose ... | There are just a handful of big medical device companies that dominate the continuous glucose monito... | medcitynew... |
